On March 15, 2018 Crescendo Biologics Limited (Crescendo), the drug developer of novel,
targeted T-cell engaging therapeutics, reported that Colette Johnston, Senior Director, will be
presenting at the 11th Annual Proteins & Antibodies Congress in London, UK on 17 April 2018 (Press release, Crescendo Biologics, MAR 15, 2018, View Source [SID1234525092]).The 11th Annual Proteins & Antibodies Congress is being held in London from 16–17 April and brings together over 450 attendees, ranging from global pharmaceutical organisations and leading biotech
companies to internationally renowned academic institutions.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Colette will present a talk on "Developing Differentiated Humabody VH Therapeutics for Oncology"
within the ‘Antibody Engineering, Design & Development’ and ‘Protein & Antibody Biotherapeutics’
streams. Several other scientists from Crescendo will also be in attendance.

Title: Developing Differentiated Humabody VH Therapeutics for Oncology
Date: Tuesday 17 April 2018
Time: 17.00
Location: Novotel London West Hotel, 1 Shortlands, Hammersmith International Centre, London, UK
W6 8DR
E